Codexis, Inc. (CDXS) Stock Price

CDXSStock

$1.24−53.03%52W

Market Cap$135.79M

P/E—

PEG Ratio13.53

Div yield—

Beta2.38

CDXS Share Price Chart

Favorite Metrics

Price vs S&P 500 (26W)-57.58%

Price vs S&P 500 (4W)-8.82%

PEG Ratio13.53

VGM Score42.22

Book Value / Share (Quarterly)$0.36

P/TBV (Annual)9.72x

Indicated Dividend (Annual)$0.00

Revenue Growth (3Y)-20.22%

Cash Flow / Share (Quarterly)$-0.13

Price vs S&P 500 (YTD)-35.85%

Gross Margin (TTM)87.02%

Net Profit Margin (TTM)-39.55%

EPS (TTM)$-0.34

10-Day Avg Trading Volume0.84M

EPS Excl Extra (TTM)$-0.34

Revenue Growth (5Y)0.37%

EPS (Annual)$-0.50

ROI (Annual)-48.52%

Gross Margin (Annual)86.73%

Net Profit Margin (5Y Avg)-65.14%

Cash / Share (Quarterly)$0.60

Revenue Growth QoQ (YoY)-2.69%

ROA (Last FY)-29.75%

Revenue Growth TTM (YoY)35.89%

EBITD / Share (TTM)$-0.25

ROE (5Y Avg)-61.75%

Operating Margin (TTM)-35.61%

Cash Flow / Share (Annual)$-0.26

P/B Ratio4.12x

P/B Ratio (Quarterly)6.23x

Net Income / Employee (Annual)$-301,200

EV / Revenue (TTM)1.92x

Net Interest Coverage (TTM)-137.00x

ROA (TTM)-23.58%

EV / EBITDA (TTM)245.07x

EPS Incl Extra (Annual)$-0.50

Current Ratio (Annual)3.82x

Quick Ratio (Quarterly)2.85x

3-Month Avg Trading Volume1.05M

52-Week Price Return-53.03%

Revenue / Employee (TTM)$532,000

Tangible BV / Share (Quarterly)$0.74

P/S Ratio (Annual)1.93x

Asset Turnover (Annual)0.48x

52-Week High$2.98

Operating Margin (5Y Avg)-62.68%

EPS Excl Extra (Annual)$-0.50

CapEx CAGR (5Y)3.58%

Tangible BV CAGR (5Y)-26.04%

26-Week Price Return-47.68%

Quick Ratio (Annual)3.53x

13-Week Price Return-44.64%

Total Debt / Equity (Annual)0.79x

Current Ratio (Quarterly)3.06x

Enterprise Value$149.49M

Revenue / Share Growth (5Y)-7.04%

Asset Turnover (TTM)0.60x

Book Value / Share Growth (5Y)-26.73%

Revenue / Employee (Annual)$482,100

Inventory Turnover (Annual)5.16x

Pretax Margin (Annual)-62.41%

Cash / Share (Annual)$0.86

3-Month Return Std Dev76.95%

Gross Margin (5Y Avg)78.46%

Net Income / Employee (TTM)$-210,400

ROE (Last FY)-87.03%

EPS Basic Excl Extra (Annual)$-0.50

P/FCF (TTM)6.94x

Receivables Turnover (TTM)5.52x

Total Debt / Equity (Quarterly)1.24x

EPS Incl Extra (TTM)$-0.34

Receivables Turnover (Annual)4.76x

ROI (TTM)-37.64%

P/S Ratio (TTM)1.75x

Pretax Margin (5Y Avg)-65.02%

Revenue / Share (Annual)$0.81

Tangible BV / Share (Annual)$0.46

Price vs S&P 500 (52W)-68.56%

Year-to-Date Return-23.93%

5-Day Price Return-12.06%

EPS Normalized (Annual)$-0.50

ROA (5Y Avg)-30.29%

Net Profit Margin (Annual)-62.47%

Month-to-Date Return-10.79%

Cash Flow / Share (TTM)$-1.13

EBITD / Share (Annual)$-0.42

Operating Margin (Annual)-59.30%

LT Debt / Equity (Annual)0.79x

ROI (5Y Avg)-48.16%

LT Debt / Equity (Quarterly)1.03x

EPS Basic Excl Extra (TTM)$-0.34

P/TBV (Quarterly)8.55x

P/B Ratio (Annual)2.91x

Inventory Turnover (TTM)5.69x

Pretax Margin (TTM)-39.46%

Book Value / Share (Annual)$0.56

Price vs S&P 500 (13W)-47.33%

Beta2.38x

P/FCF (Annual)45.72x

Revenue / Share (TTM)$0.85

ROE (TTM)-74.36%

52-Week Low$0.96

vGradeC

gGradeC

mGradeD

vgmGradeC

CDXS Earnings Surprise History

Quarter	Report date	EPS estimate	EPS actual	Surprise
Q2 2026	Aug 11, 2026	-$0.12	-$0.13	-8.33%(-$0.01)
Q1 2026	May 7, 2026	-$0.10	-$0.10	+4.76%(+$0.01)
Q4 2025	Mar 11, 2026	-$0.04	$0.14	+508.57%(+$0.18)
Q3 2025	Nov 6, 2025	-$0.13	-$0.22	-73.68%(-$0.09)
Q2 2025	Aug 13, 2025	-$0.15	-$0.16	-6.67%(-$0.01)

CDXS Analyst Recommendations

Jun 2026

Jul 2026

Aug 2026

Sep 2026

4.08

Industry Peers — Industrial Chemicals(25)

Symbol	Value Score	Growth Score	Momentum Score	P/S Ratio (TTM)	Revenue Growth TTM (YoY)	Gross Margin (TTM)	EPS Growth (5Y)	Price
CDXSCodexis, Inc.	C	C	D	1.7x	35.9%	87.0%	—	$1.24
IFFInternational Flavors & Fragrances Inc.	C	D	A	2.3x	-11.7%	37.5%	—	$90.68
LYBLyondellBasell Industries N.V. Class A	B	D	A	0.7x	-11.3%	12.8%	-15.3%	$64.01
WLKWestlake Corporation	B	C	C	0.7x	-4.0%	9.6%	7.3%	$63.33
NEUNewMarket Corporation	C	C	B	2.9x	-1.3%	31.5%	12.6%	$876.01
SXTSensient Technology Corporation	D	C	A	3.3x	8.1%	34.9%	4.0%	$133.74
MEOHMethanex Corp	B	B	A	1.2x	19.3%	28.6%	16.2%	$64.96
REXREX American Resources Corp.	B	B	B	2.0x	5.3%	21.5%	72.8%	$41.72
GPREGreen Plains, Inc.	B	D	B	0.6x	-23.7%	16.0%	—	$14.47
WLKPWESTLAKE CHEMICAL PARTNERS LP	A	C	B	0.6x	12.1%	31.2%	-6.0%	$20.80
BAKBraskem S.A. American Depositary Shares (Each representing Two Class A Preferred Shares)	C	D	D	0.0x	-31.1%	8.9%	—	$1.66
GEVOGevo, Inc.	B	B	D	1.6x	121.4%	47.4%	—	$1.17
ALTOAlto Ingredients, Inc. Common Stock	B	D	C	0.3x	1.1%	6.8%	—	$3.45
FFFuture Fuel Corporation	B	D	A	1.6x	-7.6%	-11.1%	-29.4%	$5.58
LODEComstock Inc.	D	C	D	134.1x	-69.1%	-165.6%	—	$1.79
AMTXAemetis, Inc. (DE) Common Stock	C	C	C	0.5x	-1.7%	10.9%	—	$1.46
LNZALanzaTech Global, Inc. Common Stock	A	C	D	1.0x	43.8%	44.6%	—	$4.62
SAFXXCF Global, Inc. Class A Common Stock	B	F	F	3.8x	—	-16.8%	—	$0.14
VGASVerde Clean Fuels, Inc. Class A Common Stock	—	—	C	—	—	—	—	$0.98
TOMZTOMI Environmental Solutions, Inc.	C	C	C	1.7x	11.4%	52.9%	—	$1.47
TANHTantech Holdings Ltd. Class A Common Shares	A	D	D	0.2x	-10.7%	18.6%	—	$13.62
ORGNOrigin Materials, Inc. Common Stock	A	F	D	0.4x	-53.3%	4.1%	—	$0.95
CNEYCN Energy Group Inc. Class A Ordinary Shares	A	C	D	0.1x	-30.2%	1.8%	—	$0.41
LNZAWLanzaTech Global, Inc. Warrant	—	—	B	—	—	—	—	$0.01
ORGNWOrigin Materials, Inc. Warrants	—	—	F	—	—	—	—	$0.00
VGASWVerde Clean Fuels, Inc. Warrant	—	—	D	—	—	—	—	$0.01

About Codexis, Inc.

Codexis develops proprietary enzymatic solutions for biopharmaceutical and diagnostics manufacturing using its CodeEvolver technology platform. The company's enzymes improve production efficiency through higher yields and reduced energy consumption while enabling scaled manufacturing of RNAi therapeutics via its ECO Synthesis platform. Applications span small molecule pharmaceuticals, nucleic acid synthesis, and genomic diagnostics, with primary revenue generation from the Americas.